Clinical Trial Update: A Pilot Study to Assess the Clinical Utility of PYLARIFY PET-CT for Detecting Metastasis in Pancreatic Cancer, Hepatocellular Carcinoma and Breast Cancer [Phase 1]

View source ↗

Summary

Phase 1 pilot study evaluating the clinical utility of Pylarify PET-CT for detecting metastasis in pancreatic cancer, hepatocellular carcinoma, and breast cance…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Hepatocellular Carcinoma
• Pancreatic Cancer

Drugs mentioned

• Pylarify (piflufolastat F-18)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Pancreatic Cancer, Breast Cancer | Phase 1 | Status: RECRUITING